Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;81(2):318-356.
doi: 10.1016/j.jinf.2020.04.031. Epub 2020 Apr 29.

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France

Affiliations

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France

Chloé Dimeglio et al. J Infect. 2020 Aug.

Abstract

A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy.

Keywords: SARS-CoV-2; deconfinement; seroprevalence; statistical model.

PubMed Disclaimer

Figures

Figure 1
Fig. 1
Dynamics of SARS-CoV-2 infection per day from January 22, 2020 to March 30, 2021 according to the seroprevalence before and after containment. a: no containment, b: seroprevalence before 8.3% and after 17.5%, c: seroprevalence before 15.4% and after 29.1%, d: seroprevalence before 31.9% and after 49%, e: seroprevalence before 40% and after 56.7%.
Figure 2
Fig. 2
Progressive deconfinement strategies and their impact on infection rebound. a: complete removal of containment on June 30, b: complete removal of containment on October 25.

Comment in

References

    1. Perlman S. Another Decade, Another Coronavirus. N. Engl. J. Med. 2020 doi: 10.1056/NEJMe2001126. - DOI - PMC - PubMed
    1. WHO Virtual press conference on COVID-19—11 March 2020. https://www.who.int/docs/default-source/coronaviruse/transcripts/who-aud... (2020).
    1. Saglietto A., D'Ascenzo F., Biondi Zoccai G., Maria de Ferrari G. COVID-19 in Europe: the Italian lesson. Lancet. 2020 - PMC - PubMed
    1. Legido-Quigley H. The resilience of the Spanish health system against the COVID-19 pandemic. Lancet. 2020 - PMC - PubMed
    1. Wu J.T., Leung K. Nowcasting and forecasting the potential domestic and international spread of the 2019-ncov outbreak originating in wuhan, china: a modelling study. Lancet. 2020;395(3) - PMC - PubMed

MeSH terms